Back
Janux Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
47
JANX
Janux Therapeutics
Last Price:
$23.99
Seasonality Move:
-0.89%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing slight selling pressure.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.51 | Buy |
20-day SMA: | 24.14 | Buy |
50-day SMA: | 25.82 | Sell |
200-day SMA: | 39.56 | Sell |
8-day EMA: | 23.59 | Buy |
20-day EMA: | 20.91 | Buy |
50-day EMA: | 13.65 | Buy |
200-day EMA: | 4.57 | Buy |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.87 | Buy |
Relative Strength Index (14 RSI): | 50.76 | Buy |
Chaikin Money Flow: | 26298 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Janux Therapeutics Technical Analysis
Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 24.45 while JANX 8-day simple moving average is 23.51, which is a Buy signal.
-
The stock price of JANX is 24.45 while Janux Therapeutics 20-day SMA is 24.14, which makes it a Buy.
-
Janux Therapeutics 50-day simple moving average is 25.82 while JANX share price is 24.45, making it a Sell technically.
-
JANX stock price is 24.45 and Janux Therapeutics 200-day simple moving average is 39.56, creating a Sell signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
47
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a SellThe current Janux Therapeutics [JANX] share price is $24.45. The Score for JANX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
1.4B
Price in USD:
24.45
Share Volume:
302.4K
Janux Therapeutics 52-Week Range
52-Week High:
71.71
52-Week Low:
22.48
Sell
47
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?The Janux Therapeutics stock price is 24.45 USD today.
-
Will JANX stock go up or go down?Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Janux Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 24.45 while JANX 8-day exponential moving average is 23.59, which is a Buy signal.
-
The stock price of JANX is 24.45 while Janux Therapeutics 20-day EMA is 20.91, which makes it a Buy.
-
Janux Therapeutics 50-day exponential moving average is 13.65 while JANX share price is 24.45, making it a Buy technically.
-
JANX stock price is 24.45 and Janux Therapeutics 200-day simple moving average is 4.57, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.30 per share, a decrease this year of $0.81 per share, and a decrease next year of $0.71 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
-
JANX Moving Average Covergence Divergence (MACD) indicator is 3.87, suggesting Janux Therapeutics is a Buy
-
Janux Therapeutics Relative Strength Index (RSI) is 50.76, which suggest Janux Therapeutics is overbought
-
The Bollinger Bands (25) for Janux Therapeutics is ( - ), which suggest Janux Therapeutics is a Buy
-
The Bollinger Bands (100) for Janux Therapeutics is ( - ), which suggest Janux Therapeutics is a Buy
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.